Nabilone
Other Antiemetics
Sold as CESAMET
- Drug class
- Other Antiemetics
- Availability
- See label
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 15
Overview
Nabilone is an active pharmaceutical ingredient in the Other Antiemetics group (A04AD). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 12 | March 22, 2025 |
| GB United Kingdom | MHRA | 3 | May 15, 2026 |
CACanada· Health Canada
12 products
Who should not take it
NCESAMET® (nabilone) is contraindicated in patients with known sensitivity to marijuana or other cannabinoid agents, and in those with a history of psychotic reactions. WARNINGS NCESAMET® (nabilone) should be used with extreme caution in patients with severe liver dysfunction and in those with a history of non-psychotic emotional disorders.
NCESAMET® should not be taken with alcohol, sedatives, hypnotics, or other psychotomimetic substances. NCESAMET® should not be used during pregnancy, in nursing mothers, or pediatric patients since its safety under these conditions has not been established.
PRECAUTIONS Since NCESAMET® (nabilone) will often impair the mental and/or physical abilities required for the performance of potentially hazardous tasks, such as driving a car and operating machinery, the patient should be warned accordingly and should not be permitted to drive or engage in dangerous tasks until the effects of nabilone are no longer present.
GBUnited Kingdom· MHRA
3 products
Uses
Nabilone is indicated for the control of nausea and vomiting, caused by chemotherapeutic agents used in the treatment of cancer, in patients who have failed to respond adequately to conventional antiemetic treatments.
How to take
Drug interactions
Known interactions involving Nabilone. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 312. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]Health Canada (DPD) · 00548375 · revised March 22, 2025
- [2]MHRA (UK) · PL463020113 · revised May 15, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.